25riskM

Market Quick Take - November 27, 2020

Macro 6 minutes to read

Summary:  Equities in Asia traded mixed overnight while U.S. Futures - led by the Nasdaq - rose ahead of a holiday shortened trading session for U.S. stocks and bonds. The dollar traded softer on a drop in U.S. bond yields while the yen rose against most major currencies as global coronavirus cases continue to surge higher. Gold and silver remain stuck close to key support, oil trades lower amid tensions ahead of next week's OPEC+ meeting while copper traded near a seven-year high on falling global inventories led by China.


What is our trading focus?

  • Nasdaq 100 (USNAS100.I) and S&P 500 (US500.I) - US equities are exhibiting low energy due to Thanksgiving holiday and thus we do not expect big moves in today’s session. Yesterday’s low at around 3,615 is a key support level in S&P 500 futures, if the market wants to test risk-off today.

  • Bitcoin Tracker ETN (BITCOIN_XBTE:xome) and Ethereum Tracker ETN (ETHEREUM_XBTE:xome) - Bitcoin was down 16.8% at the lows yesterday compared to the high the day before as the market sold off heavily on comment from the CEO of Coinbase (digital currency exchange) voicing concerns over potential regulatory crackdown. This combined with the high leverage positions in the crypto market caused a violent drop. Bitcoin is up 6.3% from yesterday’s lows and up 1.2% from yesterday’s close. We have no firm on the direction but expect volatility to remain high. The positive session in Chinese equities could add some support to crypto currencies.

  • EURUSD – EURUSD is grinding higher again today as risk-on continues to build momentum across all markets. EURUSD sits at 1.1930 in early European trading and if the high from yesterday at 1.1941 can be taken out then the 1.2000 level is psychologically in sight for traders.

  • China A50 Dec (CNZ0) - Chinese main equity index up 1.5% in today’s session driven by a positive reaction to government statistics showing industrial profit was up 28.2% y/y in October up from 10.1% y/y in September suggesting profitability is even stronger than before Covid-19 underscoring the country’s success in controlling the pandemic. The strong momentum in Chinese equities will most likely lift sentiment among all emerging market equities.

  • Brent crude oil (OILUKJAN21) and WTI crude oil (OILUSJAN21) have paused ahead of next week's crucial OPEC and OPEC+ meetings starting on Monday. Following the strong vaccine-led rally some profit taking has emerged ahead of the meetings amid signs of division. The recent rally has, despite a continued surge in coronavirus cases, been driven by expectations for a vaccine-led recovery in global fuel demand. Despite objections from Iraq and UAE, the group needs to postpone the planned January production hike. Failure to do so could hurt sentiment and recently established long positions.   

  • HG Copper (COPPERUSMAR21) surged to a near seven-year high at $3.40/lb in Asian trading on a continued plunge in global inventories amid China’s economic recovery. Adding to the current strong momentum, which is being lent considerable tailwind by speculative buying interest, is the market’s belief in a post-pandemic pickup in demand outside Asia. A weaker dollar against the yuan, strong Chinese demand and falling inventories combined with copper’s importance in the green transformation have all been part of the story that has seen the metal rally 70% from the March low.

  • Portuguese sovereigns fell below 0% in yield, Spanish sovereigns soon to follow (FBONZ0). Portuguese sovereigns are to be added to the negative yielding pile of debt that is constantly growing. The only European sovereigns offering a yield above 0% in 10-year notes are now Spain, Italy and Greece, Spanish Bonos will most likely join the negative yielding club soon as the ECB is expected to add more stimulus at the next monetary policy meeting.

What is going on?

  • U.S. 10-year real yields are falling and are pushing investors to higher-yielding junk. We find that US high-yield corporate bonds offer a higher buffer against rising inflation compared to emerging market bonds. US investment-grade corporates which provide an average real yield of around 100bps are barely protecting investors from overshooting inflation. The Federal Reserve's average inflation targeting framework (AIT) might prove a dangerous monetary policy as the economy recovers. See link

  • E-commerce stocks are up 67% this year in USD terms and are showing no sign of ending their momentum. But rising global container rates hitting levels 84% above the long-term average since 2011 and bottlenecks in last-mile delivery are pushing up logistics costs for e-commerce businesses. Q3 earnings releases from JD.com and Zalando are confirming these observations with EBITDA margins under pressure. Could this be a negative surprise in the making in Q4 that investors are completely overlooking? See link

  • AstraZeneca plans new global trial over initial trial uncertainty. Investors and regulators have been confused over AstraZeneca’s trial data related to their Covid-19 vaccine as it indicated better efficacy with lower doses, but the company acknowledged production errors while running the trials which were shared with regulators. However, the confusion has created uncertainty which is not good for the planned rollout of the vaccine, so AstraZeneca is planning a new global trial.

  • Amazon unions in several countries are planning protests on Black Friday. Around 40,000 workers are expected to strike today demanding better working conditions at Amazon fulfillment warehouses including higher pay.

  • Chinas hit on Australian wine exports is the latest escalation in an ongoing diplomatic rift between the two countries. Diplomatic tensions between the two countries have mounted as Australia called for an investigation and inquiry into the COVID-19 breakout. Since then, Australia has refused to be strong-armed by Chinese threats and as a result, the tensions have not cooled. Already coal, barley and other agricultural products have been caught in the crossfire. The tariffs of more than 200% on some Australian wine the latest in the feud. Winemakers have long relied on Chinese demand and China is the largest purchaser of Aussie wine.

What we are watching next?

  • Commodities are increasingly looking towards the post-pandemic recovery in global growth and demand. In addition, the sector has already benefitted from a strong recovery in Asian demand led by China while weather concerns have lifted agriculture commodity prices. Investors are also focusing on the impact of continued fiscal and monetary spending and with that the risk of a weaker dollar and rising inflation. While the spot market fluctuates with short term demand and supply developments, the forward curves are increasingly pointing towards a strong 2021 for commodities. See link

  • Winner and losers among retailers over Black Friday weekend. Next week the market will digest numbers over the Black Friday weekend deciding which retailers and brand did well. Historically, these analyses have moved retailers quite a lot so expect trading opportunities next week.

  • Venezuelan rum maker Santa Teresa didn’t proceed with the issuance of US dollar bonds yet. The rum company would have been the first Venezuelan private company to issue debt in USD. Emerging markets are in a honeymoon and in the past few weeks they were able to extend their debt maturities and lock in low interest rates, however it is unclear whether investors will be attracted to highly risky instruments such as Venezuelan private debt. We expect the EM bond bonanza to continue until Christmas with Santa Teresa testing the market as soon as next week.

Economic Calendar Highlights for today (times GMT)

  • 0745 – France CPI Nov (P)
  • 0830 – Sweden Q3 GDP
  • 0900 – Italy Consumer and Manufacturing Confidence Nov
  • 1000 – Eurozone Economic Sentiment Nov

Follow SaxoStrats on the daily Saxo Markets Call on your favorite podcast app:

Apple Sportify Soundcloud Stitcher

Disclaimer

Confidentiality and Usage:
You may not reproduce, distribute, or transmit this material or any portion thereof without prior written permission from Saxo.

Nature of Information:
The information provided herein is based on current market conditions and analysts' opinions, which may reflect personal views of the author, and are subject to change without notice. This material does not include a record of any trading prices, or an offer of, or solicitation for, or endorsement to enter into any transaction in any investment product. Any forecast on the economy, markets and economic trends of the markets provided is not necessarily indicative of the future or likely performance of the investment product subject of this material.

Responsibility and Liability:
Saxo accepts no liability for any use that may be made of these comments or for any consequences that arise from such use. Saxo does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

The information provided in this material is solely for information only. It is intended for general circulation and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. Accordingly, it should not be relied on or treated as a substitute for specific advice concerning specific situations of any person. Please seek advice from a financial adviser regarding the suitability of any investment product taking into account your specific investment objectives, financial situation or particular needs before you make a commitment to purchase an investment product. In the event that you choose not to seek advice from a financial adviser, you should consider whether any investment product mentioned in this publication is suitable for you.

Notwithstanding the above, insofar as any information provided herein contains research analyses or reports concerning any investment product authored by any foreign research house and is issued or promulgated to a person in Singapore who is not an accredited investor, expert investor, and/or institutional investor, Saxo Capital Market Pte. Ltd. accepts legal responsibility for the contents of this material to the extent required by law. Recipients of such material are to contact Saxo Capital Markets Pte. Ltd. in respect of any matters arising from, or in connection with, this material.

Risk Disclosure:
Trading in investment products involve significant risk, including the risk of losing your entire investment. Historical returns are not a guarantee of future returns. Prices can both rise and fall, and there is a risk that you will not get back the money you invested.

Conflicts of interest:
The author may hold positions in the investment products mentioned. The author does not own positions in the underlying investment product exceeding 0.5% of its market capitalisation, save as otherwise declared. The author is not permitted to trade the mentioned investment products within the first 24 hours after the publication of this article.

Saxo maintains partnerships with companies that compensate Saxo for promotional activities conducted on its platform. Additionally, Saxo has agreements with certain partners who provide retrocession contingent upon clients purchasing specific investment products offered by these partners. While Saxo receives compensation from these partnerships, all content is conducted with the intention of providing clients with valuable options and information.

Publication details:
If any listed companies are the subject of the material, the content has not been submitted to the companies in question prior to publication.

Please refer to our full disclaimer and notification on non-independent investment research for more details.

Saxo Markets
88 Market Street
CapitaSpring #31-01
Singapore 048948

Contact Saxo

Singapore
Singapore

Saxo Capital Markets Pte Ltd ('Saxo Markets') is a company authorised and regulated by the Monetary Authority of Singapore (MAS) [Co. Reg. No.: 200601141M ] and is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms & Risk Warning to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Saxo is part of the J. Safra Sarasin Group.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products such as Margin FX products may result in your losses exceeding your initial deposits. Saxo Markets does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Markets does not take into account an individual’s needs, objectives or financial situation.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-sg/about-us/awards.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website are not intended for residents of the United States, Malaysia and Japan. Please click here to view our full disclaimer.

This advertisement has not been reviewed by the Monetary Authority of Singapore.

Apple and the Apple logo are trademarks of Apple Inc, registered in the US and other countries and regions. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC.